Tech Center 1600 • Art Units: 1619
This examiner grants 39% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17637022 | AQUEOUS DISPERSIONS INCLUDING POLYMER PARTICLES | Final Rejection | NORTH CAROLINA STATE UNIVERSITY |
| 17040190 | THERMOPLASTIC MATERIALS INCORPORATING BIOACTIVE INORGANIC ADDITIVES | Final Rejection | Evonik Operations GmbH |
| 17630052 | COMPLEMENT ACTIVE FRAGMENT-LOADED THREE-DIMENSIONAL BIOMATERIAL FOR DENTAL AND/OR OTHER TISSUE REGENERATION | Final Rejection | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE |
| 17998374 | BLONANSERIN-CONTAINING PATCH AND PRODUCTION METHOD THEREFOR | Final Rejection | KANEKA CORPORATION |
| 17904266 | EXTRUSION PRINTING OF BIOCOMPATIBLE SCAFFOLDS | Non-Final OA | William Marsh Rice University |
| 17382666 | BONDED POWDERS FOR THE TREATMENT OF BODILY LESIONS | Final Rejection | Cook Medical Technologies LLC |
| 17755462 | CERAMIC SCAFFOLD | Final Rejection | University of Southern California |
| 17623390 | BIOENERGETIC COMBINATIONS AND METHODS OF USING SAME | Final Rejection | Conopco, Inc., d/b/a UNILEVER |
| 17769713 | TRANSDERMAL ABSORPTION-TYPE PATCH | Final Rejection | KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION |
| 18036203 | ASENAPINE-CONTAINING PATCH | Final Rejection | HISAMITSU PHARMACEUTICAL CO., INC. |
| 18035951 | METHOD FOR INHIBITING ASENAPINE DEGRADATION | Final Rejection | HISAMITSU PHARMACEUTICAL CO., INC. |
| 18283587 | 3D PRINTING BONE-REGENERATION SCAFFOLDS COMPOSED OF BIOLOGICALLY-DERIVED BONE POWDER | Non-Final OA | COLORADO STATE UNIVERSITY RESEARCH FOUNDATION |
| 18618600 | ANTIMICROBIAL CUPROUS OXIDE-CONTAINING COATINGS | Non-Final OA | Vapor Technologies, Inc. |
| 17615559 | Polyvalent Dosage Forms and Method For Their Production | Non-Final OA | DiHeSys Digital Health Systems GmbH |
| 18372209 | CELLULOSE DERIVATIVE FREE CAPSULE FOR HERBAL EXTRACTS | Non-Final OA | GAIA HERBS |
| 18000215 | Bio-Material Composition and Methods of Use | Non-Final OA | Bone Solutions, Inc. |
| 18042996 | METHODS OF FORMING BONE INTERFACE SCAFFOLDS | Non-Final OA | SPARTA BIOPHARMA LLC |
| 18071410 | ADHESIVE MATRIX WITH HYDROPHILIC AND HYDROPHOBIC DOMAINS AND A THERAPEUTIC AGENT | Final Rejection | Corium, LLC |
| 17925515 | SLOW-RELEASE MEDICAL PLASTER | Non-Final OA | FIDIA FARMACEUTICI S.P.A. |
| 17560316 | BONE REGENERATION MATERIAL | Non-Final OA | Wishbone |
| 17613645 | DEVICE AND METHOD FOR DECONTAMINATION/DISINFECTION | Final Rejection | Aquila Bioscience Limited |
| 17285940 | MAMMAL-DERIVED MATRIX AS A SAFE BONE REPLACEMENT | Non-Final OA | IVORY GRAFT LTD. |
| 15765759 | COMPOSITIONS AND METHODS FOR TREATMENT OF BONE DEFECTS | Final Rejection | EMBIOS GMBH |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy